Cargando…

Angiotensin 1-7: A Novel Strategy in COVID-19 Treatment

Detalles Bibliográficos
Autores principales:	Imanpour, Hamed, Rezaee, Haleh, Nouri-Vaskeh, Masoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539308/ https://www.ncbi.nlm.nih.gov/pubmed/33062600 http://dx.doi.org/10.34172/apb.2020.068

Ejemplares similares

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
por: Rezaee, Haleh, et al.
Publicado: (2021)

Renin Angiotensin Converting Enzyme 2 and COVID-19: Prevention and Treatment
por: Kafami, Marzieh, et al.
Publicado: (2021)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020)

Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism
por: Nouri-Vaskeh, Masoud, et al.
Publicado: (2020)

Altered hepatitis C testing and treatment beyond the COVID-19 pandemic
por: Karimi-Sari, Hamidreza, et al.
Publicado: (2022)

To do or not to do: Angiotensin converting enzyme inhibitors/angiotensin receptor blocker in COVID-19 elderly patients
por: Vura, Naga Venkata Rama Krishna, et al.
Publicado: (2021)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
por: Meng, Xiao, et al.
Publicado: (2020)

Re: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID‐19?
por: Liu, Xiao, et al.
Publicado: (2020)

Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
por: Garg, Aakash, et al.
Publicado: (2020)

COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

Neurological effects of elevated levels of angiotensin II in COVID-19 patients
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

COVID-19 and angiotensin-converting enzyme inhibitors from plant origin
por: Gharebaghi, Reza, et al.
Publicado: (2022)

The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
por: McLachlan, Craig Steven
Publicado: (2020)

Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view
por: Shirazi, Farshad M., et al.
Publicado: (2020)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link
por: Van den Eynde, Jef, et al.
Publicado: (2021)

Another perspective for COVID-19 pandemic: Angiotensin-converting enzyme 2 and ethnicity
por: Simsek, Feride Irem, et al.
Publicado: (2020)

Congestive heart failure is the leading cause of pleural effusion in the north-west of Iran
por: Nazemiyeh, Masoud, et al.
Publicado: (2019)

Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges
por: Roosta, Yousef, et al.
Publicado: (2021)

Reply to “Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link”
por: Elgendy, Islam Y., et al.
Publicado: (2021)

Increased circulating levels of angiotensin-(1–7) in severely ill COVID-19 patients
por: Valle Martins, Ana Luiza, et al.
Publicado: (2021)

Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.)
por: Ekiz, Timur, et al.
Publicado: (2020)

Gustatory dysfunctions in COVID-19 patients: possible involvement of taste renin-angiotensin system (RAS)
por: Bigiani, Albertino
Publicado: (2020)

Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19
por: Bombardini, Tonino, et al.
Publicado: (2020)

An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China
por: Wang, Jin, et al.
Publicado: (2022)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

Treatment with angiotensin II in COVID-19 patients may not be beneficial
por: Rysz, Susanne, et al.
Publicado: (2020)

In Pursuit of COVID-19 Treatment Strategies: Are We Triggering Antimicrobial Resistance?
por: Hashmi, Furqan Khurshid, et al.
Publicado: (2020)

Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases
por: Motamed, Mohammad Reza, et al.
Publicado: (2015)

Fluconazole prophylaxis against invasive candidiasis in very low and extremely low birth weight preterm neonates: a systematic review and meta-analysis
por: Robati Anaraki, Mahmoud, et al.
Publicado: (2020)

Clinical Utility of Red Cell Distribution Width in Patients with Pleural Effusion
por: Rezaeifar, Parisa, et al.
Publicado: (2020)

What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?
por: John, Thadathilankal-Jess, et al.
Publicado: (2020)

Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19
por: Valenzuela, Rita, et al.
Publicado: (2021)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

Thromboprophylaxis strategies for COVID-19 patients
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19
por: Vofo, Gaelle, et al.
Publicado: (2020)

Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19
por: Dabaghian, Farid, et al.
Publicado: (2020)

Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19
por: Tsiambas, Evangelos, et al.
Publicado: (2020)

Alert on Racial Discrimination in COVID-19 Vaccination
por: Mohammadi, Masoud
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bot3dgduauntb2ib19stdp7cdt